View Financial HealthBioceres Crop Solutions 배당 및 자사주 매입배당 기준 점검 0/6Bioceres Crop Solutions 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-1.6%자사주 매입 수익률총 주주 수익률-1.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • May 05Bioceres Crop Solutions Corp. to Report Q3, 2026 Results on May 12, 2026Bioceres Crop Solutions Corp. announced that they will report Q3, 2026 results at 12:30 PM, US Eastern Standard Time on May 12, 2026공지 • Jan 12Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026. Location: 1290 avenue of the americas, ny 10104, new york United States공지 • Jan 01+ 1 more updateBioceres Crop Solutions Corp. Announces Board and Committee ChangesBioceres Crop Solutions Corp. announced changes to the composition of the board of directors of the Company. Duraiswami ("D") Narain has been appointed as a member of the Board of Directors, effective December 29, 2025. Mr. Narain has served as a non-executive director of RiceTec Inc. since 2025 and as an independent non-executive director of Medi Assist Healthcare Services Ltd. since 2024. Mr. Narain is also a founding partner of AgVaya, an organisation that collaborates with agri businesses, food companies and developmental organizations to create sustainable opportunities and drive growth in smallholder agricultural markets. Mr. Narain served as vice chairman, managing director and chief executive officer of Bayer CropScience Limited from December 2018 to October 2023, and concurrently as president at Bayer South Asia and global head of smallholder farming at Bayer. He previously served as vice president and treasurer of Monsanto Company from November 2015 to October 2018, and held various senior finance and commercial roles at Monsanto from 1998, including chief executive officer of Monsanto's India region. Mr. Narain received an MBA from the Kellogg School of Management at Northwestern University, is a chartered accountant from the Institute of Chartered Accountants of India, and holds a Bachelor of Commerce degree from the University of Madras. Mr. Narain will fill the resulting vacancy and will serve on the committees previously composed by Ms. Zang, including as chair of the audit committee.공지 • Oct 31Bioceres Crop Solutions Corp. announced delayed 20-F filingOn 10/30/2025, Bioceres Crop Solutions Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC.공지 • Oct 30Bioceres Crop Solutions Corp. to Report Q1, 2026 Results on Nov 13, 2025Bioceres Crop Solutions Corp. announced that they will report Q1, 2026 results Pre-Market on Nov 13, 2025공지 • Oct 02Bioceres Crop Solutions Corp. Announces Resignation of Noah Kolatch as A Member of the Board of Directors, Effective September 30, 2025Bioceres Crop Solutions Corp. informs that, effective September 30, 2025, Noah Kolatch resigned as a member of the board of directors of the Company, in connection with the delivery of the reservation of rights letter delivered to the Company by Jasper Lake, through counsel, dated September 25, 2025, a copy of which is filed herewith as Exhibit 99.1. In response to the Kramer Letter, the Company delivered a reservation of rights letter to Jasper Lake on September 30, 2025, disputing that any Events of Default have occurred under the Note Purchase Agreements and reinforcing that it is in the best interest of the Company and all of its stakeholders to engage in a productive dialogue with Jasper Lake to address any legitimate concern it may have, a copy of which is filed herewith as Exhibit 99.2. The Company is committed to maintaining its focus on improving its commercial and financial performance and delivering innovative solutions to the agricultural market.공지 • Sep 03Bioceres Crop Solutions Corp. to Report Q4, 2025 Results on Sep 09, 2025Bioceres Crop Solutions Corp. announced that they will report Q4, 2025 results at 12:30 PM, US Eastern Standard Time on Sep 09, 2025공지 • Aug 21Bioceres Crop Solutions Corp. Announces CFO Changes, Effective from August 20, 2025Bioceres Crop Solutions Corp. announced that the board of directors (the “Board”) of the Company and Mr. Enrique Lopez Lecube, Chief Financial Officer, have agreed to initiate a transition in the Company’s financial leadership. Effective August 20, 2025, Mr. Lopez Lecube will step down from his appointment as Chief Financial Officer, and Scott Crocco, a member of the Board, will act solely to assist in managing the finance departments of the Company on an interim basis. The Company has initiated a market search for a new Chief Financial Officer. During his tenure, Mr. Lopez Lecube has made significant contributions to the Company’s financial strategy and expansion.공지 • Jun 20Bioceres Crop Solutions Announces Changes to Board of Directors, Effective from June 24, 2025Bioceres Crop Solutions Corp. announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jasper Lake LLC, a family investment office that invests across public and private markets. Prior to joining Jasper Lake, Mr. Kolatch was a Partner at Solel Partners, a Boston-based investment firm focused on public equity and credit investments. Mr. Kolatch graduated summa cum laude from Columbia College with a BA in biochemistry. Scott Crocco is a seasoned executive with over three decades of experience in finance and operations across public and private companies. Mr. Crocco was CFO of Air Products & Chemicals Inc, where he led corporate restructuring and portfolio transformation, and later served as Chief Financial Officer of Imperial Dade, a private equity-backed distributor. Mr. Crocco holds a BS in Electrical Engineering from Bucknell University and an MBA from Cornell University. Gloria Montaron Estrada, who has served as a Director since February 2019, and Keith McGovern, who has served as a Non-Executive Director since July 2022, have each resigned from the Company's Board of Directors with effect from June 24, 2025. Enrique Lopez Lecube, the Company's Chief Financial Officer and member of the Company's senior management team, will rotate off the Company's Board of Directors. The resulting vacancy will be filled by Milen Marinov, the Company's Chief Commercial Officer and member of the Company's senior management team. These changes will also be effective from June 24, 2025.공지 • May 10Bioceres Crop Solutions Corp. to Report Q3, 2025 Results on May 21, 2025Bioceres Crop Solutions Corp. announced that they will report Q3, 2025 results on May 21, 2025공지 • Mar 12Bioceres Crop Solutions and ProFarm Group's Platform, Rinotec, Receives Federal Registration from the U.S. Environmental Protection AgencyBioceres Crop Solutions and ProFarm Group announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA’s assessment of its negligible risk to human health and non-target organisms. Rinotec has already been approved for commercialization in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial strategies in these regions, offering growers a powerful alternative that reduces reliance on traditional chemical pesticides. These approvals highlight the product’s strong efficacy profile and position Bioceres Crop Solutions to capitalize on growing market opportunities in two of the world’s largest agricultural economies.공지 • Mar 06Bioceres Crop Solutions Secures Patent Protection for Hb4 Wheat in the U.S. Until 2042Bioceres Crop Solutions Corp. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-OO412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved tolerance to drought and enhanced weed management options compared to conventional wheat. The technology has already been approved by the USDA for cultivation and by the FDA for food and feed use in the United States. The U.S. is the fourth largest wheat producer, with nearly 40 million acres harvested in the most recent marketing year. In alignment with the company's commitment to responsible commercialization, Bioceres Crop Solutions will adhere to the U.S. Wheat Associates' (USW) "Wheat Industry Principles for Biotechnology Commercialization" developed with the National Association of Wheat Growers (NAWG). These principles include maintaining fluent dialogue with USW/NAWG, securing regulatory approvals for food and feed in major wheat export markets, establishing tolerance thresholds for low level presence, providing trait detection tests, and ensuring product stewardship through education, outreach and a certified seed value capture model. The commercial rollout of HB4 wheat in the U.S. will follow a broad licensing approach, consistent with the company's recently announced go-to-market strategy for its HB4 technology.공지 • Feb 06Bioceres Crop Solutions Corp. Provides Earnings Guidance for the Second Quarter Ended December 31, 2024Bioceres Crop Solutions Corp. provided earnings guidance for the second quarter ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year.공지 • Jan 30Bioceres Crop Solutions Corp. to Report Q2, 2025 Results on Feb 12, 2025Bioceres Crop Solutions Corp. announced that they will report Q2, 2025 results on Feb 12, 2025공지 • Oct 31Bioceres Crop Solutions Corp. to Report Q1, 2025 Results on Nov 12, 2024Bioceres Crop Solutions Corp. announced that they will report Q1, 2025 results on Nov 12, 2024공지 • Oct 04Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024. Location: 1290 avenue of the americas, new york, 10104, new york United States공지 • Aug 27Bioceres Crop Solutions Corp. to Report Q4, 2024 Results on Sep 10, 2024Bioceres Crop Solutions Corp. announced that they will report Q4, 2024 results on Sep 10, 2024공지 • May 08Bioceres Crop Solutions Corp. Announces Brazil’s Approval of New Generation Bio-InsecticideBioceres Crop Solutions Corp. announced the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company’s proprietary Burkholderia platform. The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres’ most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulation stability, as well as greater consistency in their mode of action compared to live microbes. Moreover, non-living bacteria-based products can be formulated with increased potency and at much lower costs, nearing cost parity to less favorable present-day chemical alternatives. Bioceres products based on Burkholderia-derived metabolites were first registered in the United States in 2014 and have since been commercialized in Mexico, Peru, Chile, Turkey, and parts of Africa. In the United States alone, they are used as nematicidal and insecticidal seed treatment on more than 4 million hectares (>10 million acres) of corn, cotton and soybeans, effectively replacing abamectin in seed treatments, while also boosting the control of soil-dwelling insect pests that are typically controlled by neonicotinoids, pyrethroids, and organophosphates.공지 • May 03Bioceres Crop Solutions Corp. to Report Q3, 2024 Results on May 14, 2024Bioceres Crop Solutions Corp. announced that they will report Q3, 2024 results on May 14, 2024공지 • Jan 26Bioceres Crop Solutions Corp. to Report Q2, 2024 Results on Feb 08, 2024Bioceres Crop Solutions Corp. announced that they will report Q2, 2024 results on Feb 08, 2024공지 • Nov 01+ 1 more updateBioceres Crop Solutions Corp. to Report Q1, 2024 Results on Nov 14, 2023Bioceres Crop Solutions Corp. announced that they will report Q1, 2024 results on Nov 14, 2023공지 • Oct 12Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023, at 10:00 US Eastern Standard Time. Location: 1290 Avenue of the Americas New York United States Agenda: To consider the report of the Board of Directors of the Company and the report of the independent auditors of the Company’s consolidated financial statements for the financial year ended June 30, 2023 and to approve the Company’s consolidated financial statements for the financial year ended June 30, 2023; to consider and vote upon a proposal to appoint the seven directors; and to consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.공지 • Aug 31Bioceres Crop Solutions Corp. to Report Q4, 2023 Results on Sep 11, 2023Bioceres Crop Solutions Corp. announced that they will report Q4, 2023 results on Sep 11, 2023공지 • Jan 27Bioceres Crop Solutions Corp. to Report Q2, 2023 Results on Feb 09, 2023Bioceres Crop Solutions Corp. announced that they will report Q2, 2023 results on Feb 09, 2023지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 BIOXD 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: BIOXD 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Bioceres Crop Solutions 배당 수익률 vs 시장BIOXD의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (BIOXD)n/a시장 하위 25% (AR)1.0%시장 상위 25% (AR)7.5%업계 평균 (Chemicals)3.7%분석가 예측 (BIOXD) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 BIOXD 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 BIOXD 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 BIOXD 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: BIOXD 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/06 08:24종가2026/05/06 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bioceres Crop Solutions Corp.는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Brian Kemp DolliverBrookline Capital MarketsAustin MoellerCanaccord Genuity
공지 • May 05Bioceres Crop Solutions Corp. to Report Q3, 2026 Results on May 12, 2026Bioceres Crop Solutions Corp. announced that they will report Q3, 2026 results at 12:30 PM, US Eastern Standard Time on May 12, 2026
공지 • Jan 12Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026. Location: 1290 avenue of the americas, ny 10104, new york United States
공지 • Jan 01+ 1 more updateBioceres Crop Solutions Corp. Announces Board and Committee ChangesBioceres Crop Solutions Corp. announced changes to the composition of the board of directors of the Company. Duraiswami ("D") Narain has been appointed as a member of the Board of Directors, effective December 29, 2025. Mr. Narain has served as a non-executive director of RiceTec Inc. since 2025 and as an independent non-executive director of Medi Assist Healthcare Services Ltd. since 2024. Mr. Narain is also a founding partner of AgVaya, an organisation that collaborates with agri businesses, food companies and developmental organizations to create sustainable opportunities and drive growth in smallholder agricultural markets. Mr. Narain served as vice chairman, managing director and chief executive officer of Bayer CropScience Limited from December 2018 to October 2023, and concurrently as president at Bayer South Asia and global head of smallholder farming at Bayer. He previously served as vice president and treasurer of Monsanto Company from November 2015 to October 2018, and held various senior finance and commercial roles at Monsanto from 1998, including chief executive officer of Monsanto's India region. Mr. Narain received an MBA from the Kellogg School of Management at Northwestern University, is a chartered accountant from the Institute of Chartered Accountants of India, and holds a Bachelor of Commerce degree from the University of Madras. Mr. Narain will fill the resulting vacancy and will serve on the committees previously composed by Ms. Zang, including as chair of the audit committee.
공지 • Oct 31Bioceres Crop Solutions Corp. announced delayed 20-F filingOn 10/30/2025, Bioceres Crop Solutions Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC.
공지 • Oct 30Bioceres Crop Solutions Corp. to Report Q1, 2026 Results on Nov 13, 2025Bioceres Crop Solutions Corp. announced that they will report Q1, 2026 results Pre-Market on Nov 13, 2025
공지 • Oct 02Bioceres Crop Solutions Corp. Announces Resignation of Noah Kolatch as A Member of the Board of Directors, Effective September 30, 2025Bioceres Crop Solutions Corp. informs that, effective September 30, 2025, Noah Kolatch resigned as a member of the board of directors of the Company, in connection with the delivery of the reservation of rights letter delivered to the Company by Jasper Lake, through counsel, dated September 25, 2025, a copy of which is filed herewith as Exhibit 99.1. In response to the Kramer Letter, the Company delivered a reservation of rights letter to Jasper Lake on September 30, 2025, disputing that any Events of Default have occurred under the Note Purchase Agreements and reinforcing that it is in the best interest of the Company and all of its stakeholders to engage in a productive dialogue with Jasper Lake to address any legitimate concern it may have, a copy of which is filed herewith as Exhibit 99.2. The Company is committed to maintaining its focus on improving its commercial and financial performance and delivering innovative solutions to the agricultural market.
공지 • Sep 03Bioceres Crop Solutions Corp. to Report Q4, 2025 Results on Sep 09, 2025Bioceres Crop Solutions Corp. announced that they will report Q4, 2025 results at 12:30 PM, US Eastern Standard Time on Sep 09, 2025
공지 • Aug 21Bioceres Crop Solutions Corp. Announces CFO Changes, Effective from August 20, 2025Bioceres Crop Solutions Corp. announced that the board of directors (the “Board”) of the Company and Mr. Enrique Lopez Lecube, Chief Financial Officer, have agreed to initiate a transition in the Company’s financial leadership. Effective August 20, 2025, Mr. Lopez Lecube will step down from his appointment as Chief Financial Officer, and Scott Crocco, a member of the Board, will act solely to assist in managing the finance departments of the Company on an interim basis. The Company has initiated a market search for a new Chief Financial Officer. During his tenure, Mr. Lopez Lecube has made significant contributions to the Company’s financial strategy and expansion.
공지 • Jun 20Bioceres Crop Solutions Announces Changes to Board of Directors, Effective from June 24, 2025Bioceres Crop Solutions Corp. announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jasper Lake LLC, a family investment office that invests across public and private markets. Prior to joining Jasper Lake, Mr. Kolatch was a Partner at Solel Partners, a Boston-based investment firm focused on public equity and credit investments. Mr. Kolatch graduated summa cum laude from Columbia College with a BA in biochemistry. Scott Crocco is a seasoned executive with over three decades of experience in finance and operations across public and private companies. Mr. Crocco was CFO of Air Products & Chemicals Inc, where he led corporate restructuring and portfolio transformation, and later served as Chief Financial Officer of Imperial Dade, a private equity-backed distributor. Mr. Crocco holds a BS in Electrical Engineering from Bucknell University and an MBA from Cornell University. Gloria Montaron Estrada, who has served as a Director since February 2019, and Keith McGovern, who has served as a Non-Executive Director since July 2022, have each resigned from the Company's Board of Directors with effect from June 24, 2025. Enrique Lopez Lecube, the Company's Chief Financial Officer and member of the Company's senior management team, will rotate off the Company's Board of Directors. The resulting vacancy will be filled by Milen Marinov, the Company's Chief Commercial Officer and member of the Company's senior management team. These changes will also be effective from June 24, 2025.
공지 • May 10Bioceres Crop Solutions Corp. to Report Q3, 2025 Results on May 21, 2025Bioceres Crop Solutions Corp. announced that they will report Q3, 2025 results on May 21, 2025
공지 • Mar 12Bioceres Crop Solutions and ProFarm Group's Platform, Rinotec, Receives Federal Registration from the U.S. Environmental Protection AgencyBioceres Crop Solutions and ProFarm Group announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA’s assessment of its negligible risk to human health and non-target organisms. Rinotec has already been approved for commercialization in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial strategies in these regions, offering growers a powerful alternative that reduces reliance on traditional chemical pesticides. These approvals highlight the product’s strong efficacy profile and position Bioceres Crop Solutions to capitalize on growing market opportunities in two of the world’s largest agricultural economies.
공지 • Mar 06Bioceres Crop Solutions Secures Patent Protection for Hb4 Wheat in the U.S. Until 2042Bioceres Crop Solutions Corp. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-OO412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved tolerance to drought and enhanced weed management options compared to conventional wheat. The technology has already been approved by the USDA for cultivation and by the FDA for food and feed use in the United States. The U.S. is the fourth largest wheat producer, with nearly 40 million acres harvested in the most recent marketing year. In alignment with the company's commitment to responsible commercialization, Bioceres Crop Solutions will adhere to the U.S. Wheat Associates' (USW) "Wheat Industry Principles for Biotechnology Commercialization" developed with the National Association of Wheat Growers (NAWG). These principles include maintaining fluent dialogue with USW/NAWG, securing regulatory approvals for food and feed in major wheat export markets, establishing tolerance thresholds for low level presence, providing trait detection tests, and ensuring product stewardship through education, outreach and a certified seed value capture model. The commercial rollout of HB4 wheat in the U.S. will follow a broad licensing approach, consistent with the company's recently announced go-to-market strategy for its HB4 technology.
공지 • Feb 06Bioceres Crop Solutions Corp. Provides Earnings Guidance for the Second Quarter Ended December 31, 2024Bioceres Crop Solutions Corp. provided earnings guidance for the second quarter ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year.
공지 • Jan 30Bioceres Crop Solutions Corp. to Report Q2, 2025 Results on Feb 12, 2025Bioceres Crop Solutions Corp. announced that they will report Q2, 2025 results on Feb 12, 2025
공지 • Oct 31Bioceres Crop Solutions Corp. to Report Q1, 2025 Results on Nov 12, 2024Bioceres Crop Solutions Corp. announced that they will report Q1, 2025 results on Nov 12, 2024
공지 • Oct 04Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024. Location: 1290 avenue of the americas, new york, 10104, new york United States
공지 • Aug 27Bioceres Crop Solutions Corp. to Report Q4, 2024 Results on Sep 10, 2024Bioceres Crop Solutions Corp. announced that they will report Q4, 2024 results on Sep 10, 2024
공지 • May 08Bioceres Crop Solutions Corp. Announces Brazil’s Approval of New Generation Bio-InsecticideBioceres Crop Solutions Corp. announced the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company’s proprietary Burkholderia platform. The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres’ most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulation stability, as well as greater consistency in their mode of action compared to live microbes. Moreover, non-living bacteria-based products can be formulated with increased potency and at much lower costs, nearing cost parity to less favorable present-day chemical alternatives. Bioceres products based on Burkholderia-derived metabolites were first registered in the United States in 2014 and have since been commercialized in Mexico, Peru, Chile, Turkey, and parts of Africa. In the United States alone, they are used as nematicidal and insecticidal seed treatment on more than 4 million hectares (>10 million acres) of corn, cotton and soybeans, effectively replacing abamectin in seed treatments, while also boosting the control of soil-dwelling insect pests that are typically controlled by neonicotinoids, pyrethroids, and organophosphates.
공지 • May 03Bioceres Crop Solutions Corp. to Report Q3, 2024 Results on May 14, 2024Bioceres Crop Solutions Corp. announced that they will report Q3, 2024 results on May 14, 2024
공지 • Jan 26Bioceres Crop Solutions Corp. to Report Q2, 2024 Results on Feb 08, 2024Bioceres Crop Solutions Corp. announced that they will report Q2, 2024 results on Feb 08, 2024
공지 • Nov 01+ 1 more updateBioceres Crop Solutions Corp. to Report Q1, 2024 Results on Nov 14, 2023Bioceres Crop Solutions Corp. announced that they will report Q1, 2024 results on Nov 14, 2023
공지 • Oct 12Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023, at 10:00 US Eastern Standard Time. Location: 1290 Avenue of the Americas New York United States Agenda: To consider the report of the Board of Directors of the Company and the report of the independent auditors of the Company’s consolidated financial statements for the financial year ended June 30, 2023 and to approve the Company’s consolidated financial statements for the financial year ended June 30, 2023; to consider and vote upon a proposal to appoint the seven directors; and to consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.
공지 • Aug 31Bioceres Crop Solutions Corp. to Report Q4, 2023 Results on Sep 11, 2023Bioceres Crop Solutions Corp. announced that they will report Q4, 2023 results on Sep 11, 2023
공지 • Jan 27Bioceres Crop Solutions Corp. to Report Q2, 2023 Results on Feb 09, 2023Bioceres Crop Solutions Corp. announced that they will report Q2, 2023 results on Feb 09, 2023